Therefore, a new model that combined CK-18 M30, CAP, FBG, and HBVDNA level based on logistic regression might represent a simple, noninvasive, and convenient method to predict NASH in patients with CHB plus NAFLD. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatotic liver disease.